Christophe Loretan
Keine laufenden Positionen mehr
Vermögen: 51 336 $ am 30.04.2024
Profil
Christophe Loretan worked as the Director-Technical Service & Sales at Novozymes Switzerland AG from 2013 to 2015.
Prior to that, he was the Manager-Business Development at Tillotts Pharma AG from 2002 to 2003.
From 1998 to 2002, he worked as the Marketing Manager at Geistlich Pharma AG.
Additionally, he served as the Manager-Global Sales at Coltene Holding AG in 2015 and 2016.
Mr. Loretan holds an MBA from Rochester Christian University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
COLTENE HOLDING AG
0,02% | 31.12.2022 | 916 ( 0,02% ) | 51 336 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Christophe Loretan
Unternehmen | Position | Ende |
---|---|---|
Novozymes Switzerland AG | Vertrieb & Marketing | 01.01.2015 |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Corporate Officer/Principal | 01.01.2003 |
Geistlich Pharma AG
Geistlich Pharma AG Miscellaneous Commercial ServicesCommercial Services Geistlich Pharma AG researches, manufactures and provides pharmaceutical products, gelatine products, biomaterials and industrial glues. It offers Geistlich Bio-Oss and Geistlich Bio-Gide products. The firm specializes in biomaterials for the regeneration of bone, cartilage and tissue and develops, and manufactures medical devices. The company was founded in 1851 and is headquartered in Wolhusen, Switzerland. | Vertrieb & Marketing | 01.01.2002 |
COLTENE HOLDING AG | Vertrieb & Marketing | - |
Ausbildung von Christophe Loretan
Rochester Christian University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COLTENE HOLDING AG | Health Technology |
Private Unternehmen | 3 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
Geistlich Pharma AG
Geistlich Pharma AG Miscellaneous Commercial ServicesCommercial Services Geistlich Pharma AG researches, manufactures and provides pharmaceutical products, gelatine products, biomaterials and industrial glues. It offers Geistlich Bio-Oss and Geistlich Bio-Gide products. The firm specializes in biomaterials for the regeneration of bone, cartilage and tissue and develops, and manufactures medical devices. The company was founded in 1851 and is headquartered in Wolhusen, Switzerland. | Commercial Services |
Novozymes Switzerland AG |